台灣臨床試驗主持人資料庫|TPIDB

2014-11-03 - 2016-11-01

Phase II

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF AC 201 IN SUBJECTS WITH GOUT

Condition/Disease

Osteoarthritis
Test Drug

AC-201

Participate Sites
8Sites

Terminated7Sites

Study ended1Sites

黃春明

China Medical University Hospital

Division of Rheumatology

2013-01-01 - 2015-12-31

Phase III

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Month Trial of Leuco-methylthioninium bis(hydromethanesulfonate) in Subjects with Mild to Moderate Alzheimer's Disease

Condition/Disease

Alzeheimer's Disease
Test Drug

LMTM

Participate Sites
6Sites

Terminated5Sites

Study ended1Sites

楊玉婉

China Medical University Hospital

Division of Neurology

2013-07-01 - 2021-06-30

Phase II

A Randomized, Controlled Phase 2 Study Evaluating LY2875358 plus Erlotinib versus Erlotinib as First-Line Treatment in Metastatic Non–Small Cell Lung Cancer Patients with Activating EGFR Mutations Who Have Disease Control after an 8-Week Lead-In Treatment with Erlotinib

Condition/Disease

Non–Small Cell Lung Cancer
Test Drug

LY2875358

Participate Sites
5Sites

Terminated5Sites

夏德椿

China Medical University Hospital

Division of Thoracic Medicine

2013-02-01 - 2015-08-01

Phase II

A Single-Arm, Multicenter, Open-Label, Phase 2 Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab (IMC-11F8) in the First-Line Treatment of Patients With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)

Condition/Disease

Stage IV squamous NSCLC first line treatment.
Test Drug

Necitumumab

Participate Sites
5Sites

Terminated5Sites

夏德椿

China Medical University Hospital

Division of Thoracic Medicine

2020-04-20 - 2028-06-15

Phase III

A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis

Condition/Disease

Moderately to Severely Active Ulcerative Colitis
Test Drug

Mirikizumab (LY3074828)

Participate Sites
2Sites

Recruiting2Sites

周仁偉

China Medical University Hospital

Digestive System Department

2016-07-01 - 2019-01-09

Phase II

PHASE II STUDY OF COMBINED TEMOZOLOMIDE AND TARGETED P53 GENE THERAPY (SGT-53) FOR TREATMENT OF PATIENTS WITH RECURRENT GLIOBLASTOMA

Condition/Disease

GLIOBLASTOMA
Test Drug

SGT-53

Participate Sites
1Sites

Study ended1Sites

周德陽

China Medical University Hospital

Division of Orthopedics

2013-07-01 - 2015-01-31

Phase II

Randomized, Open Label, Phase 2 Study of MM-111 and Paclitaxel with or without Trastuzumab in Patients with ‘Traditional’ and ‘Non-Traditional’ HER2 Expressing Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach Who Have Failed Front Line Metastatic or Locally Advanced Therapy

Condition/Disease

Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach
Test Drug

MM-111

Participate Sites
4Sites

Terminated3Sites

Study ended1Sites

白禮源

China Medical University Hospital

Division of Hematology & Oncology

2014-10-01 - 2016-12-31

Phase II

A multi-centre, double-blind, placebo controlled, proof of concept study to evaluate the efficacy and tolerability of BAF312 in patients with polymyositis

Condition/Disease

Polymyositis (PM)
Test Drug

BAF312

Participate Sites
1Sites

Study ended1Sites

藍忠亮

China Medical University Hospital

2016-01-01 - 2019-05-31

Phase III

A 52-week, multicenter, randomized, double-blind, placebocontrolled study to assess the efficacy and safety of QAW039 when added to existing asthma therapy in patients with uncontrolled severe asthma

Condition/Disease

uncontrolled severe asthma
Test Drug

QAW039

Participate Sites
6Sites

Terminated5Sites

Study ended1Sites

許武輝醫師

China Medical University Hospital

Division of Thoracic Medicine

2018-02-01 - 2020-05-30

Phase III

A 12-week double-blind, randomized, multi-center study comparing the efficacy and safety of once monthly subcutaneous AMG 334 against placebo in adult episodic migraine patients (EMPOwER)

Condition/Disease

Episodic Migraine
Test Drug

AMG334

Participate Sites
9Sites

Terminated8Sites

Study ended1Sites

林剛旭

China Medical University Hospital

羅榮昇

Linkou Chang Gung Medical Foundation

Search Result

List